Screening for cognitive impairment in adults with sickle cell disease: A systematic review and meta-analysis
Maryline Couette(Inserm), Stéphanie Forté(University Health Network), Damien Oudin Doglioni(Université Paris-Est Créteil), Sara-Maude Desforges(Centre Hospitalier de l’Université de Montréal), Lahoud Touma(Centre Hospitalier de l’Université de Montréal), Pablo Bartolucci(UNESCO), Philippe Desmarais(McGill University), Olena Bereznyakova(Centre Hospitalier de l’Université de Montréal), Kevin H.M. Kuo(University Health Network), Christian Stapf(University of Leicester), Bénédicte Nauche(Centre Hospitalier de l’Université de Montréal), Valérie Fraïle(Centre Hospitalier de l’Université de Montréal), Justine Roy(Université de Montréal), Grégory Jacquin(Centre Hospitalier de l’Université de Montréal)
Cited by 5
Related Papers
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
|The Lancet|2013|1.2k
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
|Neurology|2006|783
Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
|The Lancet Neurology|2015|464
Demographic, Morphological, and Clinical Characteristics of 1289 Patients With Brain Arteriovenous Malformation
|Stroke|2000|409
The New York Islands AVM Study
|Stroke|2003|361